# AI for Predictive Analysis of patients on HIV treatment
## USAID-2024-0009
_[United States Agency for International Development](<../3_agency/United States Agency for International Development.md>)_ (USAID) / USAID/India


+ **The topic area that most closely aligns with the AI use case**: Health & Medical
+ **Whether the use case is implemented solely with the commercial-off-the-shelf or freely available AI products identified in Appendix B**: None of the above.
+ **Description of the AI’s intended purpose, including: (1) what problem the AI is used to solve and (2) the expected benefits and positive outcomes from the AI for an agency’s mission and/or the general public**: JHU ACCELERATE used Artificial Intelligence (AI)/Machine Learning for identifying People living with HIV(PLHIV) on treatment who are at risk of becoming lost-to-follow-up (LFU). Identifying the PLHIV on treatment who are at risk of becoming LFU will allow the project team to provide pre-emptive counselling and intervention to target/customize approaches patients who could become LFU.
+ **Description of what the AI system outputs, whether it’s a prediction, recommendation, decision, etc**: Patient risk scores
+ **The current stage of System Development Life Cycle (SDLC) for the AI use case (See System Development Life Cycle (SDLC) - Glossary | NIST CSRC)**: Retired
+ **Whether the AI use case is rights-impacting or safety-impacting, as defined in Section 6 of OMB Memorandum M-24-10. Note also that Appendix I of that memorandum lists categories of use cases that are presumed by default to impact rights and safety. If your use case falls into those lists, you must not answer “neither” to this question without a formal determination made by your agency’s Chief AI Officer, pursuant to Section 5(b) of OMB Memorandum M-24-10**: Both
+ **Date when the AI use case was retired or began the process of retirement**: 7/14/1905